Penicillin Allergy De-Labelling in Elective Surgical patients (PADLES)

  • Research type

    Research Study

  • Full title

    Penicillin Allergy De-Labelling in Elective Surgical Patients - A Study to Determine the Safety, Efficacy and Feasibility of Abbreviated Allergy Testing.

  • IRAS ID

    222993

  • Contact name

    Louise Savic

  • Contact email

    louise.savic@nhs.net

  • Sponsor organisation

    Leeds Teaching Hospitals NHS Trust

  • Duration of Study in the UK

    1 years, 6 months, 0 days

  • Research summary

    Penicillin antibiotics are safe and inexpensive, and kill selected bacteria rather than big range. Unfortunately, around 10% of the population are labelled as ‘penicillin allergic’, often based on side effects such as rash and sickness, rather than true allergy. Up to 90-95% of people with the label are not actually allergic to the drug, when tested.

    The label itself can be linked to harm. It leads to the use of alternative antibiotics, which tend to more toxic, and less specific about which bacteria they kill; this increases the risk of getting 'super-bugs', compared to patients without the label. People with the label also tend to have to stay in hospital longer, and come back into hospital more often. These are problems are bad for individuals, and also for society.

    In order to check whether someone is allergic to penicillin or not, they generally have skin tests first, where very small injections of penicillin are given into the top layer of skin. However, in reactions from a long time ago, these tests are very unreliable, and if the reaction sounds like a side effect rather than true allergy, patients are then given a dose of penicillin by mouth to see if they can take it without any problems. In some centres, patients who had rashes in childhood, nausea, and other side effects, are given penicillin by mouth without having the skin tests first. This streamlines the process, making it cheap, quicker, and easier for patients. The pathway is recommended in Australia and New Zealand, but is not yet standard in the UK.

    We aim to show that this pathway offers a safe, quick, and effective way to remove the penicillin allergy label in large numbers of patients undergoing routine surgery.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    17/YH/0096

  • Date of REC Opinion

    28 Apr 2017

  • REC opinion

    Further Information Favourable Opinion